| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 19613129
[patent_doc_number] => 20240398809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => TREATMENT OF ALOPECIA AREATA
[patent_app_type] => utility
[patent_app_number] => 18/405453
[patent_app_country] => US
[patent_app_date] => 2024-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18405453
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/405453 | TREATMENT OF ALOPECIA AREATA | Jan 4, 2024 | Abandoned |
Array
(
[id] => 19613129
[patent_doc_number] => 20240398809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => TREATMENT OF ALOPECIA AREATA
[patent_app_type] => utility
[patent_app_number] => 18/405453
[patent_app_country] => US
[patent_app_date] => 2024-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18405453
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/405453 | TREATMENT OF ALOPECIA AREATA | Jan 4, 2024 | Abandoned |
Array
(
[id] => 20262900
[patent_doc_number] => 12433868
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Polymorphic forms of ST-246 and methods of preparation
[patent_app_type] => utility
[patent_app_number] => 18/545961
[patent_app_country] => US
[patent_app_date] => 2023-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 12745
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18545961
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/545961 | Polymorphic forms of ST-246 and methods of preparation | Dec 18, 2023 | Issued |
Array
(
[id] => 19096333
[patent_doc_number] => 20240115560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => SYNERGISTIC MULTIMODAL OPIOID FREE ANALGESIC FORMULATION AND METHODS FOR REDUCED POSTOPERATIVE NAUSEA AND VOMITING, INFLAMMATION, AND ENHANCED POSTOPERATIVE PAIN RELIEF
[patent_app_type] => utility
[patent_app_number] => 18/543781
[patent_app_country] => US
[patent_app_date] => 2023-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18543781
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/543781 | SYNERGISTIC MULTIMODAL OPIOID FREE ANALGESIC FORMULATION AND METHODS FOR REDUCED POSTOPERATIVE NAUSEA AND VOMITING, INFLAMMATION, AND ENHANCED POSTOPERATIVE PAIN RELIEF | Dec 17, 2023 | Pending |
Array
(
[id] => 19096334
[patent_doc_number] => 20240115561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => SYNERGISTIC MULTIMODAL OPIOID FREE ANALGESIC FORMULATION AND METHODS FOR REDUCED POSTOPERATIVE NAUSEA AND VOMITING, INFLAMMATION, AND ENHANCED POSTOPERATIVE PAIN RELIEF
[patent_app_type] => utility
[patent_app_number] => 18/543991
[patent_app_country] => US
[patent_app_date] => 2023-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18543991
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/543991 | SYNERGISTIC MULTIMODAL OPIOID FREE ANALGESIC FORMULATION AND METHODS FOR REDUCED POSTOPERATIVE NAUSEA AND VOMITING, INFLAMMATION, AND ENHANCED POSTOPERATIVE PAIN RELIEF | Dec 17, 2023 | Pending |
Array
(
[id] => 19155988
[patent_doc_number] => 20240148694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => TREATMENT OF ANDROGEN DEPRIVATION THERAPY ASSOCIATED SYMPTOMS
[patent_app_type] => utility
[patent_app_number] => 18/537308
[patent_app_country] => US
[patent_app_date] => 2023-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13282
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18537308
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/537308 | TREATMENT OF ANDROGEN DEPRIVATION THERAPY ASSOCIATED SYMPTOMS | Dec 11, 2023 | Pending |
| 18/531240 | 2-AMINO-4-(4-BROMOPHENYL)-6-METHOXYPYRIDINE-3,5-DICARBONITRILE AS AN ANTIBACTERIAL COMPOUND | Dec 5, 2023 | Abandoned |
Array
(
[id] => 19447258
[patent_doc_number] => 20240307388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => FORMULATIONS FOR SUBSTITUTED 3-PYRROLIDINES, COMPOSITIONS CONTAINING, AND USES OF SAME
[patent_app_type] => utility
[patent_app_number] => 18/501268
[patent_app_country] => US
[patent_app_date] => 2023-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18501268
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/501268 | FORMULATIONS FOR SUBSTITUTED 3-PYRROLIDINES, COMPOSITIONS CONTAINING, AND USES OF SAME | Nov 2, 2023 | Pending |
Array
(
[id] => 19104592
[patent_doc_number] => 11957663
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-04-16
[patent_title] => 3-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl) propanoic acid as an antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/385601
[patent_app_country] => US
[patent_app_date] => 2023-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4232
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18385601
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/385601 | 3-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl) propanoic acid as an antimicrobial compound | Oct 30, 2023 | Issued |
Array
(
[id] => 18971855
[patent_doc_number] => 20240051947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => (R)-2-[(2H-1,3-BENZODIOXOL-5-YL)METHYL]PYRROLIDINE AND PROCESSES FOR PREPARATION, COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/380423
[patent_app_country] => US
[patent_app_date] => 2023-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18380423
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/380423 | (R)-2-[(2H-1,3-benzodioxol-5-yl)methyl]pyrrolidine and processes for preparation, compositions and uses thereof | Oct 15, 2023 | Issued |
Array
(
[id] => 19105736
[patent_doc_number] => 11958817
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-04-16
[patent_title] => 4-chloro-n'-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/380034
[patent_app_country] => US
[patent_app_date] => 2023-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3943
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18380034
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/380034 | 4-chloro-n'-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound | Oct 12, 2023 | Issued |
Array
(
[id] => 18986315
[patent_doc_number] => 20240058284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => STAT3 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/481522
[patent_app_country] => US
[patent_app_date] => 2023-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -84
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18481522
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/481522 | STAT3 INHIBITORS | Oct 4, 2023 | Pending |
Array
(
[id] => 19845164
[patent_doc_number] => 20250090515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => 1-Deoxynojirimycin To Mitigate Hepatic Ischemia- Reperfusion
[patent_app_type] => utility
[patent_app_number] => 18/369455
[patent_app_country] => US
[patent_app_date] => 2023-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18369455
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/369455 | 1-Deoxynojirimycin To Mitigate Hepatic Ischemia- Reperfusion | Sep 17, 2023 | Abandoned |
Array
(
[id] => 19081794
[patent_doc_number] => 20240108595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => COMPOSITIONS AND METHODS FOR REVERSING AGE-ASSOCIATED DENDRITIC SPINE LOSS
[patent_app_type] => utility
[patent_app_number] => 18/464725
[patent_app_country] => US
[patent_app_date] => 2023-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18464725
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/464725 | COMPOSITIONS AND METHODS FOR REVERSING AGE-ASSOCIATED DENDRITIC SPINE LOSS | Sep 10, 2023 | Pending |
Array
(
[id] => 19081794
[patent_doc_number] => 20240108595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => COMPOSITIONS AND METHODS FOR REVERSING AGE-ASSOCIATED DENDRITIC SPINE LOSS
[patent_app_type] => utility
[patent_app_number] => 18/464725
[patent_app_country] => US
[patent_app_date] => 2023-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18464725
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/464725 | COMPOSITIONS AND METHODS FOR REVERSING AGE-ASSOCIATED DENDRITIC SPINE LOSS | Sep 10, 2023 | Pending |
Array
(
[id] => 18877416
[patent_doc_number] => 20240000785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => GONADOTROPIN-RELEASING HORMONE ANTAGONIST DOSING REGIMENS FOR TREATING UTERINE FIBROIDS AND REDUCING MENSTRUAL BLOOD LOSS
[patent_app_type] => utility
[patent_app_number] => 18/244773
[patent_app_country] => US
[patent_app_date] => 2023-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18244773
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/244773 | GONADOTROPIN-RELEASING HORMONE ANTAGONIST DOSING REGIMENS FOR TREATING UTERINE FIBROIDS AND REDUCING MENSTRUAL BLOOD LOSS | Sep 10, 2023 | Pending |
Array
(
[id] => 19097724
[patent_doc_number] => 20240116952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => KRAS INHIBITOR AND PHARMACEUTICAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/463439
[patent_app_country] => US
[patent_app_date] => 2023-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463439
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/463439 | KRAS INHIBITOR AND PHARMACEUTICAL USES THEREOF | Sep 7, 2023 | Pending |
Array
(
[id] => 19097724
[patent_doc_number] => 20240116952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => KRAS INHIBITOR AND PHARMACEUTICAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/463439
[patent_app_country] => US
[patent_app_date] => 2023-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463439
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/463439 | KRAS INHIBITOR AND PHARMACEUTICAL USES THEREOF | Sep 7, 2023 | Pending |
Array
(
[id] => 19339281
[patent_doc_number] => 12049459
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-07-30
[patent_title] => 3-(4,5-Diphenyl-2-(pyridin-3-yl)-1H-imidazol-1-yl)-N,N-dimethylpropan-1-amine as an anticancer compound
[patent_app_type] => utility
[patent_app_number] => 18/241394
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3898
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18241394
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/241394 | 3-(4,5-Diphenyl-2-(pyridin-3-yl)-1H-imidazol-1-yl)-N,N-dimethylpropan-1-amine as an anticancer compound | Aug 31, 2023 | Issued |
Array
(
[id] => 19186149
[patent_doc_number] => 20240165062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => COMPOSITION FOR INCREASING MUSCLE
[patent_app_type] => utility
[patent_app_number] => 18/456744
[patent_app_country] => US
[patent_app_date] => 2023-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18456744
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/456744 | COMPOSITION FOR INCREASING MUSCLE | Aug 27, 2023 | Pending |